15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Immutep Ltd ADR, 1 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $1.00 to $10.00 (about 10.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $5.50 sits 1449% above the current $0.35. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $-0.20 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy133%
Hold267%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Immutep Ltd ADR.
As of Sep, 1 of 3 firms rate IMMP a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IMMP EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect Immutep Ltd ADR to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier. Full-year consensus is $-0.20, growing to $-0.20 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —)., rising to $1.6M next year.
Top analysts covering Immutep Ltd ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IMMP.
#1
Joel Beatty
Baird · Rank #80
Hold
$1.00+181.7% to target
Overall win rate
48%
+ Follow
#2
Reni J. Benjamin
JMP Securities · Rank #366
Hold
No targeton IMMP
Overall win rate
32%
+ Follow
#3
Jason McCarthy
Maxim Group · Rank #428
Buy
No targeton IMMP
Overall win rate
32%
+ Follow
#4
Reni J. Benjamin
Citizens
Hold
No targeton IMMP
Coverage
—
+ Follow
#5
CK
Colleen Kusy
Baird
Hold
No targeton IMMP
Coverage
—
+ Follow
IMMP stock forecast FAQ
What is IMMP's average 12-month price target?+
The 2 analysts with a live target average $5.50 for Immutep Ltd ADR over the next 12 months, ranging from a $10.00 high to a $1.00 low.
Is IMMP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 1 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for IMMP?+
The Street-high target is $10.00 (Citizens), and the Street-low is $1.00 (Baird). The average of all 2 active targets is $5.50.
How many Wall Street analysts cover IMMP?+
3 analysts have an active rating on Immutep Ltd ADR, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering IMMP?+
Among analysts who currently cover IMMP, Joel Beatty of Baird has the strongest overall Quantellect track record (Rank #80). Their current call is Hold with a $1.00 target.
What is Immutep Ltd ADR's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts. Full-year EPS is projected at $-0.20, rising to $-0.20 the following year.
How much revenue is Immutep Ltd ADR expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at —, growing to $1.6M next year.
Have analysts been upgrading or downgrading IMMP lately?+
As of Sep, 1 of 3 firms rate IMMP a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IMMP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
